Abstract
A number of in vitro studies have implicated protein kinase Cδ(PKCδ) and PKCε in the regulation of the immune system. In recent years, this has been convincingly demonstrated in mice deficient for PKCδ and PKCε. The reported phenotypes for these transgenic mice indicate that PKCδ suppresses immunoresponsiveness and inhibits the proliferation of B-lymphocytes, while PKCε is required for macrophages to mount an effective immune response to bacterial pathogens. In either case, these isoenzymes appear to cooperate in fine-tuning certain immunoreactions by either suppressing (PKCδ) or stimulating (PKCε) the transcription of various cytokines. This review will compare and contrast the structures of these two nPKC isoenzymes and their respective roles in the modulation of cytokine production and various other cellular processes, such as growth, differentiation, apoptosis, and tumor suppression.
Keywords: Protein kinase C, PKC, isoenzymes, PKC epsilon, PKC delta
Current Pharmaceutical Design
Title: Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Volume: 12 Issue: 24
Author(s): G. Perletti and D. M. Terrian
Affiliation:
Keywords: Protein kinase C, PKC, isoenzymes, PKC epsilon, PKC delta
Abstract: A number of in vitro studies have implicated protein kinase Cδ(PKCδ) and PKCε in the regulation of the immune system. In recent years, this has been convincingly demonstrated in mice deficient for PKCδ and PKCε. The reported phenotypes for these transgenic mice indicate that PKCδ suppresses immunoresponsiveness and inhibits the proliferation of B-lymphocytes, while PKCε is required for macrophages to mount an effective immune response to bacterial pathogens. In either case, these isoenzymes appear to cooperate in fine-tuning certain immunoreactions by either suppressing (PKCδ) or stimulating (PKCε) the transcription of various cytokines. This review will compare and contrast the structures of these two nPKC isoenzymes and their respective roles in the modulation of cytokine production and various other cellular processes, such as growth, differentiation, apoptosis, and tumor suppression.
Export Options
About this article
Cite this article as:
Perletti G. and Terrian M. D., Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes, Current Pharmaceutical Design 2006; 12 (24) . https://dx.doi.org/10.2174/138161206777947498
DOI https://dx.doi.org/10.2174/138161206777947498 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypertension and Cardiac Arrhythmias
Current Pharmaceutical Design Properties of Oils From Plantain Pseudostem Biotransformed Using Crude Local Enzyme Sources: A Comparison of Poultry Feed Oil
Recent Patents on Food, Nutrition & Agriculture Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
Current Medicinal Chemistry Generation of Mesenchymal Stem Cells by Blood Cell Reprogramming
Current Stem Cell Research & Therapy Novel Biomarkers Assessing Renal Function in Heart Failure: Relation to Inflammatory Status and Cardiac Remodelling
Current Medicinal Chemistry Renin Inhibition as a New Strategy to Combat Cardiovascular Disease
Current Hypertension Reviews Asthma-COPD Overlap: A more Simplistic Approach
Current Respiratory Medicine Reviews Ca2+ Signalling in Damaged Endothelium: Do Connexin Hemichannels Aid in Filling the Gap?
Current Drug Therapy The Role of Cnidaria in Drug Discovery. A Review on CNS Implications and New Perspectives
Recent Patents on CNS Drug Discovery (Discontinued) Combined Effect of Anti-Angiogentic Agents, Angiotensin Type 1 Receptor Antagonists and Radiation Therapy
Current Signal Transduction Therapy The Renin Inhibitor Aliskiren as Novel Treatment for Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?
Anti-Cancer Agents in Medicinal Chemistry Ca2+-Handling Proteins and Heart Failure: Novel Molecular Targets?
Current Medicinal Chemistry Overview and Developments Regarding Functional Foods and Beverages
Current Nutrition & Food Science Relaxin Receptors - New Drug Targets for Multiple Disease States
Current Drug Targets A Novel Finding: Macrophages Involved in Inflammation Participate in Acute Aortic Dissection Complicated with Acute Lung Injury
Current Molecular Medicine Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism
Current Pharmaceutical Design Follistatin-like 1 in Cardiovascular Disease and Inflammation
Mini-Reviews in Medicinal Chemistry Pharmacological Inhibition of Poly(ADP-ribose) Polymerase in Cardiovascular Disorders: Future Directions
Current Vascular Pharmacology